Literature DB >> 13907003

Behavioral effects and brain amine content in rats.

S M HESS, W DOEPFNER.   

Abstract

Entities:  

Keywords:  BEHAVIOR; BRAIN/metabolism; INDOLES/metabolism; MONOAMINE OXIDASE INHIBITORS/pharmacology; SEROTONIN/metabolism; TRYPTOPHAN/pharmacology

Mesh：

Substances：

Year:  1961        PMID： 13907003

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN： 0003-9780


× No keyword cloud information.
  24 in total

1.  The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats.

Authors:  C A Marsden; G Curzon
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

2.  Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan.

Authors:  A J Sleight; C A Marsden; K F Martin; M G Palfreyman
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

3.  The subcellular distribution of histamine, slow-reacting substance and 5-hydroxytryptamine in the brain of the rat.

Authors:  E A CARLINI; J P GREEN
Journal:  Br J Pharmacol Chemother       Date:  1963-04

4.  Effects of tranylcypromine stereoisomers, clorgyline and deprenyl on open field activity during long term lithium administration in rats.

Authors:  D F Smith
Journal:  Psychopharmacology (Berl)       Date:  1976-10-20       Impact factor: 4.530

5.  Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing.

Authors:  M K Mundey; A Fletcher; C A Marsden
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

6.  Role of monoamines in behavior of reserpinized rats given tranylcypromine stereoisomers.

Authors:  D F Smith
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

7.  On the role of central nervous system catecholamines and 5-hydroxytryptamine in the nialamide-induced behavioural syndrome.

Authors:  K Modigh; T H Svensson
Journal:  Br J Pharmacol       Date:  1972-09       Impact factor: 8.739

8.  Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor.

Authors:  D G Grahame-Smith
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739

9.  Behavioural hyperactivity in rats treated with selective monoamine oxidase inhibitors and LM 5008, a selective 5-hydroxytryptamine uptake blocker.

Authors:  R Ashkenazi; J P Finberg; M B Youdim
Journal:  Br J Pharmacol       Date:  1983-07       Impact factor: 8.739

Review 10.  Use of tryptophan in combination with other antidepressant treatments: a review.

Authors:  S N Young
Journal:  J Psychiatry Neurosci       Date:  1991-12       Impact factor: 6.186
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.